Stock Events

Stock Events

Seres Therapeutics (MCRB) Q3 2023 Earnings

2NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.57

-0.2

0.18

0.55

Details

Expected EPS

-0.5

Actual EPS

-0.37

Surprise EPS

0.13

Surprise Percent

+26%

Description

Seres Therapeutics (MCRB) has reported earnings of -0.37 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.